ScopusElsevier Scopus
Not listed in Scopus.
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY is indexed in Web of Science (ESCI), DOAJ. Published by DOVE MEDICAL PRESS LTD.
ISSN 1179-9889Verify ISSN ↗
Publisher: DOVE MEDICAL PRESS LTD
WoS · ESCIOpen Access
2
Indexed in
major indexes
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Is BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY indexed in Scopus? No — BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY is not currently indexed in Scopus.
What is the impact factor of BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY? BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Is BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY in Web of Science? Yes — indexed in the Emerging Sources Citation Index.
Is BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY open access? Yes — it is an open-access journal, listed in DOAJ.
Impact & reach — open metrics via OpenAlex
18
h-index
1.13
2-yr mean citations
39
i10-index
149
works indexed
1,259
total citations
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY published 19 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.
Integrity signals — indicators, not proof of misconduct
- Scopus statusNot in the Scopus source list
- Retracted papers None recorded
Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.
Official sources & links
Related journals
- Breast Cancer: Targets and Therapy Scopus Q2 WoS SCIE
- Cancer Management and Research Scopus Q2 WoS SCIE
- Cell Health and Cytoskeleton
- Clinical and Experimental Gastroenterology Scopus Q2 WoS ESCI
- Clinical, Cosmetic and Investigational Dentistry Scopus Q2 WoS ESCI
- Clinical, Cosmetic and Investigational Dermatology Scopus Q2 WoS SCIE
- Clinical Epidemiology Scopus Q1 WoS SCIE
- Clinical Interventions in Aging Scopus Q2 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.